Evaluate, summarize: The designation is intended to expedite the development and review of drugs for serious or life threatening conditions when preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over available therapy on one or more clinically significant endpoints.
Keywords, tags: retail, schizophrenia, treatment
HTML encoding (character set): UTF-8
HTTP status code: 200
The request is OK (this is the standard response for successful HTTP requests)
Header content type: text/html; charset=UTF-8
IP address: 22.214.171.124
Country: United States
Bypass Internet Filters to Unblock Website:
Access this URL with Proxy Service
The information forward from this site may be provided by third parties. We will not be responsible with outside links, contents from source of information, methods of using, using or consequence of contents with users. All direct or indirect risk related to use of this site is borne entirely by you, the user.
We use advertising companies as Google AdSense, to serve ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. If you would like more information about this practice and to know your choices about not having this information used by these companies, see https://policies.google.com/technologies/ads.